Verwandte Artikel zu Antirheumatic Therapy: Actions and Outcomes (Progress...
Inhaltsangabe
Our goal for this book is to examine the contemporary therapy of rheumatoid arthritis (RA) from the increasingly important perspective of impact upon quality of life, costs and long-term health outcomes. For too long the focus has been on short term, symptomatic, and surrogate indicator outcomes. Yet RA is a life-long disor der with the majority of impact on an individual patient many years following onset. Further, even in the short-term, researchers and rheumatologists have tended to emphasize measurements of disease activity such as joint counts, ESR and physi cian's opinion as to the amount of disease activity present. It is only relatively recently that measures of structural damage, quality of life and impact on broad domains of health have been given increasing emphasis. Also, the significance of early treatment of RA in order to optimise long-term outcomes has a relatively short history [1]. We have been focussed on the disease processes as surrogates for long term outcomes. Until the short-term process measures are validated as surrogates of long-term effects we should also turn our attention to outcomes of disease and the impact of our management on those outcomes [2). Inour view, this book is especially timely. We are at the dawn of a revolution in the management of RA and other complex immunological inflammatory disorders because their molecular, genetic and environmental mechanisms are being unrav elled. Inthe process, we are revealing a substantial number of novel and significant targets for pharmacotherapy.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Suchergebnisse für Antirheumatic Therapy: Actions and Outcomes (Progress...
Beispielbild für diese ISBN
Antirheumatic Therapy : Actions and Outcomes; (Progress in Inflammation Research Series)
Verlag:
Birkhauser, Switzerland, 2005
ISBN 10: 3764365951
ISBN 13: 9783764365950
Gebraucht
Hardcover
Anbieter: The Book Exchange, Macclesfield, CHESH, Vereinigtes Königreich
Verkäuferbewertung 4 von 5 Sternen
Hardcover. Zustand: Near Fine. No Jacket. 3764365951. Pictorial board hardcover, from closed pharmaceutical company library. Lending record shows this book has never been borrowed. 344 pages, index, refs, illustrated with charts, photos and diagrams. A comprehensive overview of disease-modifying antirheumatic drugs (DMARDs). The introductory general chapters deal with the chemistry of DMARDs, their use in therapy, pharmacoeconomics, and a survey of opinion leaders in the field; the following specific chapters characterize each agent with regard to mechanism of action, therapy, pharmacology, efficacy, toxicity, and monitoring. For each agent some background is given, recent developments and influence of the treatment on patients` quality of life and long-term outcomes are presented. Contents clean, tight and bright. Book. Bestandsnummer des Verkäufers 028680
Gebraucht kaufen
EUR 13,12
EUR 23,32 Versand
Versand von Vereinigtes Königreich nach USA
Versand von Vereinigtes Königreich nach USA
Anzahl: 1 verfügbar
Beispielbild für diese ISBN
Antirheumatic Therapy: Actions and Outcomes.
Anbieter: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Deutschland
Verkäuferbewertung 4 von 5 Sternen
XII, 343 p. Hardcover Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Gestempelt. Progress in Inflammation Research. Sprache: Englisch. Bestandsnummer des Verkäufers 320FB
Gebraucht kaufen
EUR 12,00
EUR 30,00 Versand
Versand von Deutschland nach USA
Versand von Deutschland nach USA
Anzahl: 2 verfügbar
Beispielbild für diese ISBN
Antirheumatic Therapy: Actions and Outcomes (Progress in Inflammation Research)
Anbieter: Lexington Books Inc, Idaho Falls, ID, USA
Verkäuferbewertung 5 von 5 Sternen
Hardcover. Zustand: Good. Good+; Contents are tight and clean; Ex-Library; Hard Cover; Birkhauser; 2005; 0. Bestandsnummer des Verkäufers 80017
Gebraucht kaufen
EUR 142,83
EUR 4,96 Versand
Versand innerhalb von USA
Versand innerhalb von USA
Anzahl: 1 verfügbar
Foto des Verkäufers
Anti-Inflammatory or Anti-Rheumatic Drugs
Verlag:
Springer, Basel, Birkhäuser Basel Dez 2004, 2004
ISBN 10: 3764365951
ISBN 13: 9783764365950
Neu
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Our goal for this book is to examine the contemporary therapy of rheumatoid arthritis (RA) from the increasingly important perspective of impact upon quality of life, costs and long-term health outcomes. For too long the focus has been on short term, symptomatic, and surrogate indicator outcomes. Yet RA is a life-long disor der with the majority of impact on an individual patient many years following onset. Further, even in the short-term, researchers and rheumatologists have tended to emphasize measurements of disease activity such as joint counts, ESR and physi cian's opinion as to the amount of disease activity present. It is only relatively recently that measures of structural damage, quality of life and impact on broad domains of health have been given increasing emphasis. Also, the significance of early treatment of RA in order to optimise long-term outcomes has a relatively short history [1]. We have been focussed on the disease processes as surrogates for long term outcomes. Until the short-term process measures are validated as surrogates of long-term effects we should also turn our attention to outcomes of disease and the impact of our management on those outcomes [2). Inour view, this book is especially timely. We are at the dawn of a revolution in the management of RA and other complex immunological inflammatory disorders because their molecular, genetic and environmental mechanisms are being unrav elled. Inthe process, we are revealing a substantial number of novel and significant targets for pharmacotherapy. 343 pp. Englisch. Bestandsnummer des Verkäufers 9783764365950
Neu kaufen
EUR 160,49
EUR 23,00 Versand
Versand von Deutschland nach USA
Versand von Deutschland nach USA
Anzahl: 2 verfügbar
Foto des Verkäufers
Anti-Inflammatory or Anti-Rheumatic Drugs
Print-on-DemandAnbieter: moluna, Greven, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Comprehensive and well structured according to classes of agentsIncludes an outlook on future molecular targetsInternational authorshipOur goal for this book is to examine the contemporary therapy of rheumatoid arthritis (RA) from the inc. Bestandsnummer des Verkäufers 5279460
Neu kaufen
EUR 136,16
EUR 48,99 Versand
Versand von Deutschland nach USA
Versand von Deutschland nach USA
Anzahl: Mehr als 20 verfügbar
Beispielbild für diese ISBN
Antirheumatic Therapy: Actions and Outcomes (Progress in Inflammation Research)
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. In. Bestandsnummer des Verkäufers ria9783764365950_new
Neu kaufen
EUR 177,86
EUR 13,17 Versand
Versand von Vereinigtes Königreich nach USA
Versand von Vereinigtes Königreich nach USA
Anzahl: Mehr als 20 verfügbar
Beispielbild für diese ISBN
Antirheumatic Therapy
Anbieter: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irland
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. Offering an overview of disease-modifying antirheumatic drugs (DMARDs), this book deals with the chemistry of DMARDs, their use in therapy, pharmacoeconomics, and a survey of opinion leaders in the field. It also characterizes each agent with regard to mechanism of action, therapy, pharmacology, efficacy, toxicity, and monitoring. Editor(s): Day, Richard O.; Furst, Daniel E.; Van Riel, Piet L.; Bresnihan, Barry. Series: Progress in Inflammation Research. Num Pages: 356 pages, biography. BIC Classification: MJM; MMG. Category: (P) Professional & Vocational; (U) Tertiary Education (US: College). Dimension: 240 x 168 x 21. Weight in Grams: 782. . 2004. Hardback. . . . . Bestandsnummer des Verkäufers V9783764365950
Neu kaufen
EUR 198,28
EUR 9,50 Versand
Versand von Irland nach USA
Versand von Irland nach USA
Anzahl: 15 verfügbar
Foto des Verkäufers
Antirheumatic Therapy: Actions and Outcomes
Print-on-DemandAnbieter: preigu, Osnabrück, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Buch. Zustand: Neu. Antirheumatic Therapy: Actions and Outcomes | Richard O. Day (u. a.) | Buch | xiii | Englisch | 2004 | Springer Basel | EAN 9783764365950 | Verantwortliche Person für die EU: Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand. Bestandsnummer des Verkäufers 102445756
Neu kaufen
EUR 141,20
EUR 70,00 Versand
Versand von Deutschland nach USA
Versand von Deutschland nach USA
Anzahl: 5 verfügbar
Foto des Verkäufers
Antirheumatic Therapy: Actions and Outcomes
Verlag:
Birkhäuser Basel, Birkhäuser Basel Dez 2004, 2004
ISBN 10: 3764365951
ISBN 13: 9783764365950
Neu
Hardcover
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Buch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Our goal for this book is to examine the contemporary therapy of rheumatoid arthritis (RA) from the increasingly important perspective of impact upon quality of life, costs and long-term health outcomes. For too long the focus has been on short term, symptomatic, and surrogate indicator outcomes. Yet RA is a life-long disor der with the majority of impact on an individual patient many years following onset. Further, even in the short-term, researchers and rheumatologists have tended to emphasize measurements of disease activity such as joint counts, ESR and physi cian's opinion as to the amount of disease activity present. It is only relatively recently that measures of structural damage, quality of life and impact on broad domains of health have been given increasing emphasis. Also, the significance of early treatment of RA in order to optimise long-term outcomes has a relatively short history [1]. We have been focussed on the disease processes as surrogates for long term outcomes. Until the short-term process measures are validated as surrogates of long-term effects we should also turn our attention to outcomes of disease and the impact of our management on those outcomes [2). Inour view, this book is especially timely. We are at the dawn of a revolution in the management of RA and other complex immunological inflammatory disorders because their molecular, genetic and environmental mechanisms are being unrav elled. Inthe process, we are revealing a substantial number of novel and significant targets for pharmacotherapy.Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin 364 pp. Englisch. Bestandsnummer des Verkäufers 9783764365950
Neu kaufen
EUR 160,49
EUR 60,00 Versand
Versand von Deutschland nach USA
Versand von Deutschland nach USA
Anzahl: 1 verfügbar
Foto des Verkäufers
Antirheumatic Therapy: Actions and Outcomes
Verlag:
Birkhäuser Basel, Birkhäuser Basel, 2004
ISBN 10: 3764365951
ISBN 13: 9783764365950
Neu
Hardcover
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Our goal for this book is to examine the contemporary therapy of rheumatoid arthritis (RA) from the increasingly important perspective of impact upon quality of life, costs and long-term health outcomes. For too long the focus has been on short term, symptomatic, and surrogate indicator outcomes. Yet RA is a life-long disor der with the majority of impact on an individual patient many years following onset. Further, even in the short-term, researchers and rheumatologists have tended to emphasize measurements of disease activity such as joint counts, ESR and physi cian's opinion as to the amount of disease activity present. It is only relatively recently that measures of structural damage, quality of life and impact on broad domains of health have been given increasing emphasis. Also, the significance of early treatment of RA in order to optimise long-term outcomes has a relatively short history [1]. We have been focussed on the disease processes as surrogates for long term outcomes. Until the short-term process measures are validated as surrogates of long-term effects we should also turn our attention to outcomes of disease and the impact of our management on those outcomes [2). Inour view, this book is especially timely. We are at the dawn of a revolution in the management of RA and other complex immunological inflammatory disorders because their molecular, genetic and environmental mechanisms are being unrav elled. Inthe process, we are revealing a substantial number of novel and significant targets for pharmacotherapy. Bestandsnummer des Verkäufers 9783764365950
Neu kaufen
EUR 160,49
EUR 63,94 Versand
Versand von Deutschland nach USA
Versand von Deutschland nach USA
Anzahl: 1 verfügbar